Skip to main content
. 2018 Mar 6;88(6):920–927. doi: 10.1111/cen.13569

Table 1.

Symptoms of early OHSS using different triggers

Univariate analyses Multivariate analyses
Odds ratio (CI) P value Adj odds ratio (CI) P value
Abdominal paina
hCG 16.1 (6.7‐38.3) <.001 13.1 (4.2‐40.6) <.001
GnRHa 2.1 (1.01‐4.2) .048 2.1 (1.01‐4.2) .048
Abdominal bloatingb
hCG 35.3 (13.1‐94.8) <.001 30.7 (7.0‐134.3) <.001
GnRHa 3.4 (1.7‐6.9) .001 3.7 (1.5‐9.4) .005
Diarrhoeac
hCG 8.8 (1.6‐47.5) .011 2.9 (0.2‐35.8) .41
GnRHa 1.9 (0.3‐11.6) .489 2.4 (0.4‐14.9) .35
Nausead
hCG 24.8 (6.7‐92.3) <.001 19.4 (3.3‐115.4) .001
GnRHa 6.6 (1.8‐23.7) .004 8.2 (1.8‐37.6) .007
Vomitinge
hCG 10.1 (1.02‐99.9) .048 10.1 (1.02‐99.9) .048
GnRHa 5.1 (0.6‐46.8) .15 5.1 (0.6‐46.8) .15
Self‐reported reduction in urine outputa
hCG 13.8 (1.5‐127.8)f .021 16.1 (1.4‐188.8)f .027
GnRHa 2.5 (0.2‐28.2)f .45 2.5 (0.2‐28.2)f .45

Univariate and multivariate logistic regression analysis of associations between symptom of early OHSS following different triggers. The odds ratio of experiencing symptoms of OHSS following hCG or GnRH trigger when compared with kisspeptin trigger is presented as follows: aadjusted for use of long IVF protocol, badjusted for use of long IVF protocol and number of oocytes retrieved, cadjusted for antral follicle count and use of long IVF protocol, dadjusted for antral follicle count, total dose of recombinant FSH during stimulation and use of long IVF protocol, eno confounders identified during univariate analysis. fAs no patient with kisspeptin triggering had self‐reported reduction in urine output, Laplace smoothing was applied.